20beta-Dihydroprednisolone is a glucocorticoid compound that serves as a metabolite of prednisolone, characterized by the reduction of the 20-oxo group to a beta-hydroxy group. It is recognized as a human and mammalian metabolite, with structural features of multiple hydroxy and oxo groups on a steroid backbone.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 15847-24-2
2',6'-pipecoloxylidide
pharmaceutical raw material
Pralmorelin
pharmaceutical raw material
Montelukast
pharmaceutical raw material
(Z)-desethyl methyl tamoxifen
pharmaceutical raw material
(8S,9S,10R,11S,13S,14S,17R)-17-[(1R)-1,2-dihydroxyethyl]-11,17-dihydroxy-10,13-dimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one
LCOVYWIXMAJCDS-LCGKLAOVSA-N
C[C@]12C[C@@H]([C@H]3[C@H]([C@@H]1CC[C@@]2([C@@H](CO)O)O)CCC4=CC(=O)C=C[C@]34C)O